ERIC I RICHMAN
CIK 1313876 · CHIEF EXECUTIVE OFFICER · last filed 2025-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$852.8K
Companies
4
Total Filings
55
Lifetime Open-Market Net
-$414.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GANX | Director | 292,458 | $1.68 | $491.3K | $102.8K | 9 | 2025-06-25 |
| NeuBase Therapeutics, Inc. (NBSE) Delisted | Director | 71,707 | $0.38 | $27.1K | $96.4K | 7 | 2022-09-12 |
| ADMA | Director | 44,030 | $8.21 | $361.5K | $106.3K | 11 | 2020-03-03 |
| Altimmune, Inc. (PIP) Delisted | Director | 454,895 | — | — | -$719.7K | 24 | 2016-11-23 |
Recent Filings · Page 6 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-07-30 | Altimmune, Inc. (PIP) Delisted | Mixed | — | $0 | EDGAR |
| 2009-01-23 | Altimmune, Inc. (PIP) Delisted | Grant (A) | +30,573 | $0 | EDGAR |
| 2008-10-21 | — | Disp (D) | — | $0 | |
| 2007-10-04 | Altimmune, Inc. (PIP) Delisted | Mixed | +30,000 | $0 | EDGAR |
| 2007-02-16 | — | Grant (A) | — | $0 |
Showing 51–55 of 55
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.